lecture 37 - sae 5 Flashcards

1
Q

describe somatic cell fusion

A

gene mapping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe gene therapy

A

conventional gene therapy
genome editing and ips

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe cell hybridization/fusion

A

whole cell fusion
virus binds 2 cells – viral membrane fuses membranes of cells – makes bridge then fused together = now hybrid
high confluence - touch each other

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe hybrids created

A

hybrids containing genomes from the 2 diff cell lines
genomes of fused cells are unstable = randomly keep or lose chromosomes
hybrid between human and rodent = rodent chromosomes mostly kept and most human chromosomes lost = used to map gene of interest in human

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

is cell fusion efficient

A

noooo highly inefficient
selectable marker needed to identify hybrids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe hat medium

A

hypoxanthine aminopterin thymidine
natural marker selection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe de novo pathway

A

blocked by aminopterin
noble pathway
major dna precursors
makes newly synthesized dna

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe salvage pathway

A

minor dna precursors
salvage pathway like recycles
can live without as long as major INTACT
requires hprt for dgtp and tk for dttp = 2 genes become essential when major not working
if can provide these precursors then cell will live - even tho major pathway gone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

define hypoxanthine and thymidine

A

hypoxanthine = converted to guanine by hypoxanthine guanine phosphoribosyltransferase
thymidine = phoshorylated by thymidine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe fusion of the hprt and tk lines

A

fusion of tk deficient and hprt deficient cell = new fusion of 2 cell lines = kinda like complementation test - so now cell has tk and hprt
now full set of enzymes = survive off of minor pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe mapping measles virus receptor in humans - experiment

A

measles can only bind to primates not rodents

make hybrids between primate and rodent - some human chroms kept but most lost –> identify cells infected by measles –> determine which human chroms kept in those cells (easy since human chrom structure diff - morphologically diff from rodents)
if receptors for measles lost then no measles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe mapping measles virus receptor in humans - results

A

look at all human chroms
3/9 can be affected by measles = look at common number so chrom 1 is common in all that have measles
Probably where receptor for measles encoded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is gene therapy

A

involves adding normal wild type copy of a gene to genome of an individual carrying defective mutated copies of the gene - often recessive mutations
finding defective genes
only few of 4000 inherited human diseases are treatable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

name the 2 types of viral vectors

A

derived from adenovirus
derived from retrovirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe viral vector derived from adenovirus

A

will infect all cells even non dividing ones
vectors will not be integrated in genome = transgene diluted and eventually lost = not permanent but faster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe viral vector derived from retrovirus

A

many will infect only diving cells but others (hiv) can infect without host cell division
transgene and viral vector will be incorporated into genome of infected cells - more stable

17
Q

describe somatic gene editing

A

limited to tissue - targets genes in specific types of cells
edited gene is only contained in target cell type
any changes limited to treated individual - edited gene not passed down to future generations

18
Q

describe germline gene editing

A

made early in development so any changes copies into all of new cells = alters genome
copied in every cell = includes sperm and egg
will be passed on to future gens
new - mostly not approved since dont know effects

19
Q

which type of gene editing is more common

A

somatic gene editing

20
Q

what is somatic cell gene therapy

A

transfer of a gene in somatic cells

21
Q

what is germline gene therapy

A

transfer of a gene in all cells of an organism through germline transmission

22
Q

describe in vivo vs ex vivo gene therapy

A

in vivo = inject and hope it hits right cells
ex vivo = isolate hematopoietic target cells and alter them and then put them back in person = one can better control and monitor efficiency of gene transfer

23
Q

what does ada-scid stand for

A

adenosine deaminase - severe combined immunodeficiency disease
rare autosomal disease of immune system - bubble boy disease, affected individuals have essentially no immune system

24
Q

describe ada-scid

A

in absence of ada deoxyadenosine accumulates in t lymphocytes and eventually kills these cells - t lymphocytes responsible for stimulation of antibody producing b cells
first disease treated with gene therapy - 1990
most common treatment = bone marrow transplant

25
describe construction of an expression vector - ada-scid
sv40 promotor = very strong wild type gene = put back ada retroviral vector = allow transgene expresion in human cells long terminal repeats = needed for vector integration in cells Neomycin resistance antibiotic marker = needed for selection of human cells that will produce virus in vitro cannot replicate
26
describe partially curing scid
isolate wbcs - used vector - put ada genes - grow cells in culture - select and put cells back worked but in 2007 4/10 patients developed leukemia due to integration of retroviral vectore near proto oncogene (ltr enhances transcription and integrated next to protooncogene - promoter strong) mostly use adenoviral vector nows = due to potential consequences
27
what is rp
Retinitis pigmentosa makes cells in retina break down slowly over times = progressive vision loss - like tunnel vision
28
describe rp disease
number of mutations can result in rp disease causing mutations can be autosomal dom or recessive or x linked
29
what is treatment for rp
5% of rp caused by autosomal recessive mutation of rpe65 retinoid isomerohydrolase 2017 = luxturan approved by fda for treating patients with rpe65 mutations uses adenoviral vector, in vivo = inject into eye, quite successful
30
name 3 issues with conventional gene therapy
integration sites cannot be controlled - using retroviral one expression level of the rescue gene may not be optimal ex vivo experiment limited to certain cell types hard to control
31
what is the solution to problems with conventional gene therapy
directly edit genomic sequences of stem cells from the patient = differentiate to any cell type so can target many tissues
32
describe tools to target specific sequences in genome
do not need bunch of enzymes crispr sytem (clustered regularly interspaced short palindromic repeats) uses rna molecule to target specific dna sequences = to target diff sequences in genome = change crRNA sequences fix mutated gene into wild type
33
describe how sick cell can be treated
gene therapies = editing genome now can treat it
34
what are ips and explains
induced pluripotent stem cells if over express diff tfs (proteins) = oct3/4, sox2, c-myc and klf4 = fibroblasts will reprogram and become pluripotent stem cells can just take fibroblasts from ppl - do not need to isolate stem cells anymore mature cells can be reprogrammed to become pluripotent - no moral implication of using ips unlike embryonic stem cells
35
describe future treatments
clinical trials with pluripotent stem cells isolate somatic cells --> reprogram --> edit using crispr or other methods --> correct gene --> differentiate to cell type of interest --> back to person not chance of rejection since cells come from humans